Background
In 2008, Canadian Blood Services (CBS) implemented a new and improved method of producing platelets from whole blood donations. This new “Buffy Coat Component Production” method required significant changes to CBS and Transfusion Medicine service operations, but has brought benefits to both CBS and the recipients of blood products.
Benefits
The Buffy Coat Production method ensures that hospitals receive a pooled, bacterially tested, ready-to-transfuse platelet concentrate with a five-day shelf life. This new method is also expected to improve availability and provide a higher yield of platelets, as more of the whole blood donations can be made into platelet products.
Challenges
This change in production method required the introduction of new blood bags. Following the first CBS pilot in Edmonton in 2006, the BC Provincial Blood Coordinating Office (PBCO) facilitated the second pilot in British Columbia and the Yukon in 2007. The purpose of the project at the PBCO was to facilitate the provincial implementation of Buffy Coat while working to mitigate any potential risks to patients, staff, and product safety.